| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXGN | Common Stock | Options Exercise | $0 | +2.5K | +8.33% | $0.00 | 32.5K | Feb 22, 2025 | Direct | F1, F2 |
| transaction | AXGN | Common Stock | Tax liability | -$13.4K | -814 | -2.5% | $16.49 | 31.7K | Feb 25, 2025 | Direct | F2, F3, F4 |
| Id | Content |
|---|---|
| F1 | This reflects the number of shares issued upon the attainment of certain performance criteria. |
| F2 | The original Form 4, filed on February 26, 2025, failed to include 30,000 shares of common stock representing 30,000 restricted stock units in the beneficial number of shares of common stock outstanding in item 5 of Table I. |
| F3 | Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units ("PSUs") on February 22, 2025. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. |
| F4 | The reported price in Column 4 is a weighted average sale price. These shares were sold on February 25, 2025 in multiple transactions at prices ranging from $16.42 to $17.32 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |